254 related articles for article (PubMed ID: 35118885)
1. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
[TBL] [Abstract][Full Text] [Related]
2. Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS.
Alshehri A; Koussis N; Al-Iedani O; Arm J; Khormi I; Lea S; Lea R; Ramadan S; Lechner-Scott J
Eur J Radiol; 2024 Jan; 170():111207. PubMed ID: 37988961
[TBL] [Abstract][Full Text] [Related]
3. Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate.
Alshehri A; Al-Iedani O; Koussis N; Khormi I; Lea R; Lechner-Scott J; Ramadan S
Neuroradiol J; 2023 Aug; 36(4):388-396. PubMed ID: 36395524
[TBL] [Abstract][Full Text] [Related]
4. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
Shi Z; Pan Y; Yan Z; Ding S; Hu H; Wei Y; Luo D; Xu Y; Zhu Q; Li Y
Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
[TBL] [Abstract][Full Text] [Related]
6. The association between white matter tract structural connectivity and information processing speed in relapsing-remitting multiple sclerosis.
Chylińska M; Karaszewski B; Komendziński J; Wyszomirski A; Hałas M; Szurowska E; Sabisz A
Neurol Sci; 2023 Sep; 44(9):3221-3232. PubMed ID: 37103603
[TBL] [Abstract][Full Text] [Related]
7. The heterogeneity of tissue destruction between iron rim lesions and non-iron rim lesions in multiple sclerosis: A diffusion MRI study.
Hu H; Ye L; Ding S; Zhu Q; Yan Z; Chen X; Chen G; Feng X; Li Q; Li Y
Mult Scler Relat Disord; 2022 Oct; 66():104070. PubMed ID: 35914471
[TBL] [Abstract][Full Text] [Related]
8. T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis.
Hannoun S; Kocevar G; Codjia P; Barile B; Cotton F; Durand-Dubief F; Sappey-Marinier D
J Neuroimaging; 2022 Mar; 32(2):328-336. PubMed ID: 34752685
[TBL] [Abstract][Full Text] [Related]
9. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
10. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
Kuchling J; Backner Y; Oertel FC; Raz N; Bellmann-Strobl J; Ruprecht K; Paul F; Levin N; Brandt AU; Scheel M
Neuroimage Clin; 2018; 19():538-550. PubMed ID: 29984162
[TBL] [Abstract][Full Text] [Related]
11. Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging.
Kato S; Hagiwara A; Yokoyama K; Andica C; Tomizawa Y; Hoshino Y; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Hattori N; Abe O; Aoki S
J Neurol Sci; 2022 May; 436():120205. PubMed ID: 35259556
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging.
Caranova M; Soares JF; Batista S; Castelo-Branco M; Duarte JV
Magn Reson Imaging; 2023 Dec; 104():61-71. PubMed ID: 37775062
[TBL] [Abstract][Full Text] [Related]
13. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
[TBL] [Abstract][Full Text] [Related]
15. White matter microstructural alterations in clinically isolated syndrome and multiple sclerosis.
Huang J; Liu Y; Zhao T; Shu N; Duan Y; Ren Z; Sun Z; Liu Z; Chen H; Dong H; Li K
J Clin Neurosci; 2018 Jul; 53():27-33. PubMed ID: 29754967
[TBL] [Abstract][Full Text] [Related]
16. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study.
Kolasa M; Hakulinen U; Brander A; Hagman S; Dastidar P; Elovaara I; Sumelahti ML
Brain Behav; 2019 Jan; 9(1):e01194. PubMed ID: 30588771
[TBL] [Abstract][Full Text] [Related]
17. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
[TBL] [Abstract][Full Text] [Related]
18. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
19. Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Asaf A; Evan S; Anat A
Neuroimage Clin; 2015; 8():261-6. PubMed ID: 26106550
[TBL] [Abstract][Full Text] [Related]
20. Role of white matter in cognitive impairment among relapsing remitting multiple sclerosis patients.
Elkhooly M; Bao F; Raghib M; Millis S; Bernitsas E
Mult Scler Relat Disord; 2023 Nov; 79():105030. PubMed ID: 37837669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
